Triple-negative breast cancer (TNBC) is a subtype of breast cancer in which the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) is negative, representing approximately 15%–20% of breast neoplasms [1]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.